| Financial Year |
March 31 2023 |
| Monetary Funds |
399,350,237.30 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
234,059.96 |
| Accounts Receivable |
111,455,477.45 |
| Advances to Suppliers |
4,458,100.21 |
| Other Receivables |
2,657,271.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
54,387,763.59 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,486,772.36 |
| Total Current Assets |
593,776,035.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
166,715,676.15 |
| Under-construction Projects |
120,788,214.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
39,524,960.42 |
| R&D expenses |
-- |
| Goodwill |
2,604,229.52 |
| Long-Term Deferred and Prepaid Expenses |
1,033,793.63 |
| Deferred Income Tax Assets |
296,826.28 |
| Other Non-Current Assets |
18,150,557.84 |
| Sub-Total of Non-Current Assets |
356,423,634.66 |
| Total Assets |
950,199,670.02 |
| Short-Term Loans |
30,100,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,100,000.00 |
| Accounts Payable |
28,384,396.40 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,551,694.39 |
| Taxes Payable |
3,273,355.28 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,000,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,864,097.08 |
| Other Current Liabilities |
61,797.18 |
| Sub-Total of Current Liabilities |
74,810,703.21 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,219,189.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,994,698.07 |
| Total Liabilities |
80,805,401.28 |
| Paid-In Capital(Or Share Stock) |
192,705,526.00 |
| Capital Surplus |
447,458,505.86 |
| Surplus Reserve |
27,818,198.63 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
198,230,893.53 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
869,394,268.74 |
| Owner's Equity（Stockholder's Equity） |
869,394,268.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
950,199,670.02 |
